Patents by Inventor Harry Frank Abts

Harry Frank Abts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and methods for combined cosmetic treatment of cellulite with ultrasound
    Patent number: 11944849
    Abstract: Dermatological cosmetic combination treatments with high intensity focused ultrasound, dermal fillers, fat-reducing compounds, cavitation-prone fluids, and/or septa dissection are provided. A HIFU therapy system can include an imaging system, methods adapted to alter placement and position of a line focus band therapy, multiple simultaneous cosmetic ultrasound treatment zones in tissue, and dithering ultrasound beams from a transducer to alter placement and position of multiple cosmetic treatment zones in tissue. The HIFU systems can include a hand wand, removable transducer modules, and a control module. The dermal fillers can include hydroxyapatite. The fat-reducing compounds can include adipocytolytic compounds, pentacyclic triterpenoid compounds, proapoptotic compounds, compounds impairing differentiation of pre-adipocytes, and combinations thereof. The cavitation-prone fluids can include molecules dissolved in fluids, ethanol, glycerin, and ethylene glycol.
    Type: Grant
    Filed: February 19, 2019
    Date of Patent: April 2, 2024
    Assignee: Ulthera, Inc.
    Inventors: Rainer Pooth, Harry Frank Abts, Charles D. Emery, Wojciech Danysz
  • SYSTEMS AND METHODS FOR COMBINED COSMETIC TREATMENT OF CELLULITE WITH ULTRASOUND
    Publication number: 20210093898
    Abstract: Dermatological cosmetic combination treatments with high intensity focused ultrasound, dermal fillers, fat-reducing compounds, cavitation-prone fluids, and/or septa dissection are provided. A HIFU therapy system can include an imaging system, methods adapted to alter placement and position of a line focus band therapy, multiple simultaneous cosmetic ultrasound treatment zones in tissue, and dithering ultrasound beams from a transducer to alter placement and position of multiple cosmetic treatment zones in tissue. The HIFU systems can include a hand wand, removable transducer modules, and a control module. The dermal fillers can include hydroxyapatite. The fat-reducing compounds can include adipocytolytic compounds, pentacyclic triterpenoid compounds, proapoptotic compounds, compounds impairing differentiation of pre-adipocytes, and combinations thereof. The cavitation-prone fluids can include molecules dissolved in fluids, ethanol, glycerin, and ethylene glycol.
    Type: Application
    Filed: February 19, 2019
    Publication date: April 1, 2021
    Inventors: Rainer Pooth, Harry Frank Abts, Charles D. Emery, Wojciech Danysz
  • Topical Application of Vinca Alkaloids for the Treatment of Actinic Keratosis
    Publication number: 20150073008
    Abstract: The present invention provides pharmaceutical compositions comprising a vinca alkaloid of formula (I): or a pharmaceutically acceptable salt (or hydrate) thereof, wherein each of R1, R2, R3, and R4 is as defined and described herein, wherein said formulations are useful for the topical treatment of actinic keratosis.
    Type: Application
    Filed: September 11, 2014
    Publication date: March 12, 2015
    Inventors: Bhushan Hardas, Harry Frank Abts, Thomas Hengl, Kim Schlinzig, Alan Fleischer, Sarah Caley, Jon Parrish, Lutz Franke
  • USE OF PEGYLATED ALCOHOLS FOR THE TREATMENT OF ACTINIC KERATOSIS
    Publication number: 20140357726
    Abstract: Use of pegylated alcohols for the treatment of actinic keratosis.
    Type: Application
    Filed: November 29, 2012
    Publication date: December 4, 2014
    Inventors: Heiko Barg, Rainer Pooth, Harry Frank Abts, Kevin Kiehm
  • USE OF ADAMANTANE DERIVATIVES FOR THE TREATMENT OF ACTINIC KERATOSIS
    Publication number: 20140303246
    Abstract: Use of an adamantaneamine derivative for the treatment of actinic keratosis.
    Type: Application
    Filed: September 7, 2012
    Publication date: October 9, 2014
    Applicant: MERZ Pharma GmbH & Co. KGaA
    Inventors: Kevin Kiehm, Rainer Pooth, Harry Frank Abts